These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22769055)

  • 1. Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
    León W; Durocher J; Barrera G; Pinto E; Winikoff B
    BMC Pregnancy Childbirth; 2012 Jul; 12():65. PubMed ID: 22769055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fever following postpartum administration of sublingual misoprostol.
    Durocher J; Bynum J; León W; Barrera G; Winikoff B
    BJOG; 2010 Jun; 117(7):845-52. PubMed ID: 20406228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in Argentina.
    Durocher J; Aguirre JD; Dzuba IG; Mirta Morales E; Carroli G; Esquivel J; Martin R; Berecoechea C; Winikoff B
    Trop Med Int Health; 2020 Jun; 25(6):714-722. PubMed ID: 32155681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
    Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
    Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual misoprostol and hyperpyrexia: case report with temperature curve.
    Tolefac PN; Minkande JZ
    BMC Res Notes; 2017 Jul; 10(1):329. PubMed ID: 28747212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
    Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
    BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India.
    Patted SS; Goudar SS; Naik VA; Bellad MB; Edlavitch SA; Kodkany BS; Patel A; Chakraborty H; Derman RJ; Geller SE
    J Matern Fetal Neonatal Med; 2009 Jan; 22(1):24-8. PubMed ID: 19089777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA; Dabash R; Hassanein N; Darwish E; Ramadan MC; Nawar M; Charles D; Breebaart M; Winikoff B
    BMC Pregnancy Childbirth; 2020 May; 20(1):317. PubMed ID: 32448257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R; Rani S; Srivastav U; Makhija B
    Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual misoprostol to decrease blood loss after caesarean delivery: a randomised controlled trial.
    Ugwu IA; Enabor OO; Adeyemi AB; Lawal OO; Oladokun A; Olayemi O
    J Obstet Gynaecol; 2014 Jul; 34(5):407-11. PubMed ID: 24724983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial.
    Hofmeyr GJ; Nikodem VC; de Jager M; Drakely A
    S Afr Med J; 2001 May; 91(5):432-5. PubMed ID: 11455810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
    Othman ER; Fayez MF; El Aal DE; El-Dine Mohamed HS; Abbas AM; Ali MK
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
    Raghavan S; Abbas D; Winikoff B
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour.
    Lumbiganon P; Hofmeyr J; Gülmezoglu AM; Pinol A; Villar J
    Br J Obstet Gynaecol; 1999 Apr; 106(4):304-8. PubMed ID: 10426235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence.
    Hundley VA; Avan BI; Sullivan CJ; Graham WJ
    BJOG; 2013 Feb; 120(3):277-85; discussion 86-7. PubMed ID: 23190345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of postpartum hemorrhage with misoprostol.
    Blum J; Alfirevic Z; Walraven G; Weeks A; Winikoff B
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S202-5. PubMed ID: 17961565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.